Skip to content
Head to head

Edwards Lifesciences vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: EW · ABT

Updated 8 minutes ago

1-year performance, rebased to 100

EW +20.2%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories trades cheapest on trailing earnings; Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
EWABT
Snapshot
Sector--Medical Devices
Last price101.85103.00
Change today-1.95%-0.84%
1-year return+21.1%-15.4%
Market cap$58.56B$178.39B
52-week range74.66 – 108.0080.89 – 126.70
Valuation
P/E (TTM)57.5438.29
P/E percentile, own 5-yr range99th99th
P/B5.393.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)1.833.72
Net profit (TTM)$1.05B$6.44B
Revenue (TTM)$6.67B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+10.5%+14.5%
Gross margin78.0%56.9%
Operating margin28.8%13.8%
Net margin15.3%9.7%
Free cash flow (TTM)$1.42B$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership91.6%81.2%
Insider activity (12mo)12 buy / 38 sell36 buy / 12 sell
Short interest (% of float)1.6%1.1%
Analyst consensus95% buy / 5% hold (21)93% buy / 7% hold (15)
Analyst price target$116 (+14%)$122 (+18%)
StockVane view
StockVane Quant RatingC (63)D (22)
Company
Employees16,000115,000
Founded19581900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.